#1 Diabetes & Weight Loss Store

India’s Most TrustedPlatform for Diabetes& GLP-1 Weight Loss

Smart Devices | GLP-1 Weight Loss |
Diabetes Program | Foods & Supplements
Shop for BeatO CGM Explore GLP-1 Weight Loss
2 Million+ Patients | 10 Lakh+ Device Users | 100+ Doctors | 200+ Coaches 2 Million+ Patients | 10 Lakh+ Device Users | 100+ Doctors | 200+ Coaches 2 Million+ Patients | 10 Lakh+ Device Users | 100+ Doctors | 200+ Coaches 2 Million+ Patients | 10 Lakh+ Device Users | 100+ Doctors | 200+ Coaches 2 Million+ Patients | 10 Lakh+ Device Users | 100+ Doctors | 200+ Coaches 2 Million+ Patients | 10 Lakh+ Device Users | 100+ Doctors | 200+ Coaches 2 Million+ Patients | 10 Lakh+ Device Users | 100+ Doctors | 200+ Coaches 2 Million+ Patients | 10 Lakh+ Device Users | 100+ Doctors | 200+ Coaches
Shop for BeatO CGM Explore GLP-1 Weight Loss

Shop By Category

Smart Devices

BeatO CGM, BeatO CURV, FitScale, BP monitor

GLP-1 Weight Loss

Doctor-led program with coaching and medication

Diabetes Program

30-Day free trial includes medicines and health experts

Food & Supplements

Diabetes friendly snacks, Low GI staples and products

India's Most Advanced CGM

  • Updates Glucose Levels Every Minute
  • Bluetooth Connected. No Scanning
  • Easy One Push Application
  • Personalized AI Insights & Trends
Buy Now

BEATO CGM - 15 DAY SENSOR

Smarter Wayto Know Your Body

Lose Weight the Scientific Way

  • Highest Quality GLP-1 Medication
  • Endocrinologist Doctors for Support
  • IIHMR Certified Diet Coaches
  • Targets Appetite & Cravings
  • Smart Weighing Scale Included
Get Doctor Consult

GLP-1 WEIGHT LOSS PROGRAM

Proven Weight LossWith Expert Doctors

30-Day Free Trial Plan Includes:

  • Medicines for BP, Cholesterol and Diabetes
  • Specialist Doctor Support Included
  • IIHMR Certified Diet Coaches
Start Free Trial

DIABETES PROGRAM - FREE TRIAL

Sugar Control withDoctors & Medicines

Your Complete Diabetes Food Range

  • Low-GI Staples for Everyday Meals
  • Sugar & Weight Control Juices
  • Delicious Diabetes-Friendly Snacks
  • Health & Glucose Control Supplements
Buy Now

FOOD & SUPPLEMENTS

Specialty Foods forHealth & Sugar Control

Manage Your Health the Smart Way

  • Smartphone Connected Glucometers
  • Smart Weighing Scale with 18 Body Metrics
  • Omron BP Monitor with the BeatO App
Buy Now

OTHER MEDICAL DEVICES

Monitor YourHealth Through Data

BeatO Curv

BeatO Curv

Glucometer

BeatO Smart

BeatO Smart

Glucometer

FitScale

FitScale

Smart Scale

Omron

Omron

BP Monitor

Bestsellers

Flash Deals

Internationally Published Clinical Outcomes

Average
HbA1C drop
2.16%*
Average
Weight Loss
25%##
Users Controlled
Sugar Levels
82.9%^
Fasting
Sugar Drop
63mg/dl#

Featured In

Shop for BeatO CGMExplore GLP-1 Weight Loss

Disclaimers

Diabetes is reversible only in patients who have Type-2 diabetes or pre-diabetes. Diabetes reversal means HbA1c lesser than 6.5% in absence of pharmacologic (medication) or surgical therapy. Reversal is NOT cure. Reversal protocol is NOT recommended for people with: Advanced renal insufficiency, pancreatitis, pyruvate carboxylase deficiency, hyperchylomicronemia, cancer, eating disorders, Type-1 diabetes, pregnancy and breastfeeding. Conditions that require caution: Individuals suffering from Hypertension, Gallbladder removal, decreased Kidney Function, Kidney Stones and Gout shall require special care and caution. Diagnostic tests are offered throughout the Care Program quarterly. The individuals shown in this visual are not certified medical practitioners. Select SKUs from the medicines prescribed by the consulting doctor under the program ^Results are based on a subset of 100 users who strictly adhered to the BeatO Care program. *Results of a retrospective analysis on a cohort of 721 participants - Navneet Agrawal, Aditya Panjabi Prashant K. Dixit, Bheemaraya D (2023, June). Efficacy of digital diabetes care program in India, June 2023. diabetes (Volume 72, Issue Supplement_1, Published by American Diabetes Association) Average HbA1c reduction of participating patients in the study mentioned above (cited for indication). Individual results may vary, especially based on adherence to program, individual medical condition and lifestyle. and hence, similar outcomes are not assured. #As published in Diabetes Technology & Therapeutics, Volume 25, Issue S2, Feb 2023. ATTD, Advanced technologies and treatments for diabetes. Results are indicative and individual outcomes may vary. ##As per publicly available clinical studies. Source: https://pmc.ncbi.nlm.nih.gov/articles/PMC11940170/